Pastori, D.; Ames, P.R.J.; Triggiani, M.; Ciampa, A.; Cammisotto, V.; Carnevale, R.; Pignatelli, P.; Bucci, T.; on behalf of the ATHERO-APS Study Group.
Antiphospholipid Antibodies and Heart Failure with Preserved Ejection Fraction. The Multicenter ATHERO-APS Study. J. Clin. Med. 2021, 10, 3180.
https://doi.org/10.3390/jcm10143180
AMA Style
Pastori D, Ames PRJ, Triggiani M, Ciampa A, Cammisotto V, Carnevale R, Pignatelli P, Bucci T, on behalf of the ATHERO-APS Study Group.
Antiphospholipid Antibodies and Heart Failure with Preserved Ejection Fraction. The Multicenter ATHERO-APS Study. Journal of Clinical Medicine. 2021; 10(14):3180.
https://doi.org/10.3390/jcm10143180
Chicago/Turabian Style
Pastori, Daniele, Paul R. J. Ames, Massimo Triggiani, Antonio Ciampa, Vittoria Cammisotto, Roberto Carnevale, Pasquale Pignatelli, Tommaso Bucci, and on behalf of the ATHERO-APS Study Group.
2021. "Antiphospholipid Antibodies and Heart Failure with Preserved Ejection Fraction. The Multicenter ATHERO-APS Study" Journal of Clinical Medicine 10, no. 14: 3180.
https://doi.org/10.3390/jcm10143180
APA Style
Pastori, D., Ames, P. R. J., Triggiani, M., Ciampa, A., Cammisotto, V., Carnevale, R., Pignatelli, P., Bucci, T., & on behalf of the ATHERO-APS Study Group.
(2021). Antiphospholipid Antibodies and Heart Failure with Preserved Ejection Fraction. The Multicenter ATHERO-APS Study. Journal of Clinical Medicine, 10(14), 3180.
https://doi.org/10.3390/jcm10143180
